Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee
Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping
Pentadeca arginate (PDA) and BPC-157 should not be used by anyone outside an IRB-approved clinical research study
However, it also plays a potential role in cancer where it supplies tumors with the oxygen and nutrients needed to grow and spread
Our study revealed a significant upregulation of the GSH metabolic pathway in chemotherapy-resistant patients
Proper storage ensures the peptide remains stable and potent for the duration of your study, typically for several weeks
